Other Species / Isoforms
  HSH2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y135-p
KDPANVDyEDLFLYS
0 8
HSH2 (human) KDPANVDyEDLFLYS Y135-p
HSH2 iso2 (human) KDPANVDYEDLFLYS Y78
HSH2 (mouse) EDPANVDYEDLFLYS Y135
S175-p
QSKERKPsAEMNRIT
0 2
HSH2 (human) QSKERKPsAEMNRIT S175-p
HSH2 iso2 (human) QSKERKPSAEMNRIT S118
HSH2 (mouse) EASERKPSTTTKGEF S174
S189-p
TTKEATSsCPPKsPL
0 1
HSH2 (human) TTKEATSsCPPKsPL S189-p
HSH2 iso2 (human) TTKEATSSCPPKSPL S132
HSH2 (mouse) KGEFASASCsPKALF S185
P191
KEATSsCPPKsPLGE
0 1
HSH2 (human) KEATSsCPPKsPLGE P191
HSH2 iso2 (human) KEATSSCPPKSPLGE P134
HSH2 (mouse) EFASASCsPKALFED S187-p
S194-p
TSsCPPKsPLGETRQ
Upstream
0 5
Treatment
  • ischemia
HSH2 (human) TSsCPPKsPLGETRQ S194-p
HSH2 iso2 (human) TSSCPPKSPLGETRQ S137
HSH2 (mouse) SASCsPKALFEDSGQ A190
S206-p
TRQKLWRsLKMLPER
0 4
HSH2 (human) TRQKLWRsLKMLPER S206-p
HSH2 iso2 (human) TRQKLWRSLKMLPER S149
HSH2 (mouse) SGQKLWKNLRSLPQT N202
K249-ub
ISGPGTGkGsQDHsG
0 7
HSH2 (human) ISGPGTGkGsQDHsG K249-ub
HSH2 iso2 (human) ISGPGTGKGSQDHSG K192
HSH2 (mouse) VAQQHHSPVTRAFSW P240
S251-p
GPGTGkGsQDHsGDP
0 1
HSH2 (human) GPGTGkGsQDHsGDP S251-p
HSH2 iso2 (human) GPGTGKGSQDHSGDP S194
HSH2 (mouse) QQHHSPVTRAFSWDS T242
S255-p
GkGsQDHsGDPtsGD
0 1
HSH2 (human) GkGsQDHsGDPtsGD S255-p
HSH2 iso2 (human) GKGSQDHSGDPTSGD S198
HSH2 (mouse) SPVTRAFSWDSTSHS S246
T259-p
QDHsGDPtsGDRGyT
0 1
HSH2 (human) QDHsGDPtsGDRGyT T259-p
HSH2 iso2 (human) QDHSGDPTSGDRGYT T202
HSH2 (mouse) RAFSWDSTSHSEDSC T250
S260-p
DHsGDPtsGDRGyTD
0 1
HSH2 (human) DHsGDPtsGDRGyTD S260-p
HSH2 iso2 (human) DHSGDPTSGDRGYTD S203
HSH2 (mouse) AFSWDSTSHSEDSCA S251
Y265-p
PtsGDRGyTDPCVAT
0 24
HSH2 (human) PtsGDRGyTDPCVAT Y265-p
HSH2 iso2 (human) PTSGDRGYTDPCVAT Y208
HSH2 (mouse) gap -
K275-ub
PCVATSLksPSQPQA
0 6
HSH2 (human) PCVATSLksPSQPQA K275-ub
HSH2 iso2 (human) PCVATSLKSPSQPQA K218
HSH2 (mouse) CAATTSLQNPAEPQA Q264
S276-p
CVATSLksPSQPQAP
0 2
HSH2 (human) CVATSLksPSQPQAP S276-p
HSH2 iso2 (human) CVATSLKSPSQPQAP S219
HSH2 (mouse) AATTSLQNPAEPQAL N265
S296-p
PTRKAERsVsCIEVT
0 2
HSH2 (human) PTRKAERsVsCIEVT S296-p
HSH2 iso2 (human) PTRKAERSVSCIEVT S239
HSH2 (mouse) ATFRDSRPASWRKAF P284
S298-p
RKAERsVsCIEVTPG
Upstream
0 11
Treatment
  • ischemia
HSH2 (human) RKAERsVsCIEVTPG S298-p
HSH2 iso2 (human) RKAERSVSCIEVTPG S241
HSH2 (mouse) FRDSRPASWRKAFSG S286
S318-p
QMVVRALssQESKPE
Upstream
1 11
Treatment
  • anti-CD28
  • anti-TCR
HSH2 (human) QMVVRALssQESKPE S318-p
HSH2 iso2 (human) QMVVRALSSQESKPE S261
HSH2 (mouse) GKVVRALsAQEPVDF S306-p
S319-p
MVVRALssQESKPEH
0 1
HSH2 (human) MVVRALssQESKPEH S319-p
HSH2 iso2 (human) MVVRALSSQESKPEH S262
HSH2 (mouse) KVVRALsAQEPVDFP A307